GLP-1 Drugs Survey Report: What Employers Are and Arent Covering in 2026
Major Findings: Demonstrated an acceptable safety and tolerability profile
Blood pressure reductions, improved cholesterol profiles, and decreased inflammatory markers all suggest that Retatrutide delivers comprehensive metabolic improvement rather than simple weight reduction
Additional tirzepatide safety concerns include risk of acute gallbladder disease (presenting as right upper quadrant pain, fever, or jaundice), acute kidney injury from dehydration (especially if severe gastrointestinal symptoms occur), and hypersensitivity reactions
A healthy diet and sustainable exercise program can help reduce chronic inflammation and minimize the risks that accompany the condition
Erectile Dysfunction Some males have reported having erectile dysfunction while taking GLP-1s, though others have noted an opposite effect